Explore ARDC

RAiD https://raid.org/10.82287/e516d6db
Pipeline Accelerator - Voucher Scheme - 23-24 Round 2

Dates

Start Date
01-Mar-2024
End Date
30-Jun-2024

Titles

Title
Pipeline Accelerator - Voucher Scheme - 23-24 Round 2
Title Type
Primary
Title Type:
Primary
 Preferred full description or abstract.
Start Date
01-Mar-2024
End Date
30-Jun-2024
Language

Descriptions

No Entries

Contributors

Leader
Yes
Contact
Yes
Positions
Position
Principal or Chief Investigator
Position:
Principal or Chief Investigator
 Principal investigator refers to the person(s) in charge of a research project
Start Date
01-Mar-2024
End Date
---
Roles
No Entries

Organisations

Name
Phenomics Australia

Roles
Role
Lead Research Organisation
Role:
Lead Research Organisation
 The research organistion administratively responsible for the project; administering organisation
Start Date
2024-03-01
End Date
---

RelatedObjects

Citation

Phenomics Australia. (2024). Developing reporter lines to enhance human kidney micro-organoids. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). High-throughput identification of targets that improve kidney organoid generation protocols. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). A novel therapeutic intervention for genetic epilepsies using spider-venom peptides. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Development of Humanised Mice to Improve the Translatability for Cardiopulmonary Disease. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). FDA-approved therapeutic compound library screen to discover new drugs to treat ARID1A mutant ovarian cancer. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Identification of personalised treatment strategies for breast cancer through high-throughput screening. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). A high throughput human organoid model to measure effects of co-cultured immune cells. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Next-generation CRISPR therapeutics for autosomal dominant retinitis pigmentosa. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Deciphering the role of the kinome in skeletal muscle and their potential use as a therapeutic target in disease. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). Developing new tools to enable the translation of complement therapeutics for human disease. Phenomics Australia.
Type
Funding
Categories
Output
Citation

Phenomics Australia. (2024). A chloride ion channel as a novel therapeutic target for ischaemic heart disease. Phenomics Australia.
Type
Funding
Categories
Output

Alternate Identifier

No Entries

Alternate URLs

No Entries

Related RAiDs

No Entries

Access

Type
Open Access
Type:
Open Access
 Open access refers to a resource that is immediately and permanently online, and free for all on the Web, without financial and technical barriers.The resource is either stored in the repository or referenced to an external journal or trustworthy archive.
Language
Text
Embargo Expiry

Subjects

No Entries

Raw Data

{
  "access": {
    "type": {
      "id": "https://vocabularies.coar-repositories.org/access_rights/c_abf2/",
      "schemaUri": "https://vocabularies.coar-repositories.org/access_rights/"
    }
  },
  "alternateIdentifier": [],
  "alternateUrl": [],
  "contributor": [
    {
      "contact": true,
      "id": "https://orcid.org/0000-0002-5324-8398",
      "leader": true,
      "position": [
        {
          "id": "https://vocabulary.raid.org/contributor.position.schema/307",
          "schemaUri": "https://vocabulary.raid.org/contributor.position.schema/305",
          "startDate": "2024-03-01"
        }
      ],
      "role": [],
      "schemaUri": "https://orcid.org/",
      "status": "AUTHENTICATED",
      "orcidInfo": {
        "orcidId": "0000-0002-5324-8398",
        "displayName": "Michael Dobbie",
        "nameType": "constructed",
        "visibility": "public",
        "authenticated": true,
        "claimed": true,
        "verified": false,
        "profileUrl": "https://orcid.org/0000-0002-5324-8398",
        "style": "underline"
      }
    }
  ],
  "date": {
    "endDate": "2024-06-30",
    "startDate": "2024-03-01"
  },
  "description": [],
  "identifier": {
    "id": "https://raid.org/10.82287/e516d6db",
    "license": "Creative Commons CC-0",
    "owner": {
      "id": "https://ror.org/0201hm243",
      "schemaUri": "https://ror.org/",
      "servicePoint": 20000016,
      "servicePointName": "PhenomicsAus"
    },
    "raidAgencyUrl": "https://static.prod.raid.org.au/raids/10.82287/e516d6db",
    "registrationAgency": {
      "id": "https://ror.org/038sjwq14",
      "schemaUri": "https://ror.org/"
    },
    "schemaUri": "https://raid.org/",
    "version": 6
  },
  "metadata": {
    "created": 1780464358,
    "updated": 1780464425
  },
  "organisation": [
    {
      "id": "https://ror.org/0201hm243",
      "role": [
        {
          "id": "https://vocabulary.raid.org/organisation.role.schema/182",
          "schemaUri": "https://vocabulary.raid.org/organisation.role.schema/359",
          "startDate": "2024-03-01"
        }
      ],
      "schemaUri": "https://ror.org/",
      "rorDetails": {
        "rorId": "0201hm243",
        "name": "Phenomics Australia",
        "type": "Organization",
        "rorUrl": "https://ror.org/0201hm243"
      }
    }
  ],
  "relatedObject": [
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/5j50-5273",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Developing reporter lines to enhance human kidney micro-organoids</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/6xez-kr46",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>High-throughput identification of targets that improve kidney organoid generation protocols</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/tn8t-3173",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>A novel therapeutic intervention for genetic epilepsies using spider-venom peptides</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/5br4-d494",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Development of Humanised Mice to Improve the Translatability for Cardiopulmonary Disease</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/9k1d-b776",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>FDA-approved therapeutic compound library screen to discover new drugs to treat ARID1A mutant ovarian cancer</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/ww7y-kv68",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Identification of personalised treatment strategies for breast cancer through high-throughput screening</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/8exm-f854",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>A high throughput human organoid model to measure effects of co-cultured immune cells</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/hz3j-jw23",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Next-generation CRISPR therapeutics for autosomal dominant retinitis pigmentosa</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/xsr0-z276",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Deciphering the role of the kinome in skeletal muscle and their potential use as a therapeutic target in disease</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/3205-bb24",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>Developing new tools to enable the translation of complement therapeutics for human disease</i>. Phenomics Australia."
      }
    },
    {
      "category": [
        {
          "id": "https://vocabulary.raid.org/relatedObject.category.id/190",
          "schemaUri": "https://vocabulary.raid.org/relatedObject.category.schemaUri/386"
        }
      ],
      "id": "https://doi.org/10.82509/rf2y-md51",
      "schemaUri": "https://doi.org/",
      "type": {
        "id": "https://vocabulary.raid.org/relatedObject.type.schema/272",
        "schemaUri": "https://vocabulary.raid.org/relatedObject.type.schema/329"
      },
      "citation": {
        "text": "Phenomics Australia. (2024). <i>A chloride ion channel as a novel therapeutic target for ischaemic heart disease</i>. Phenomics Australia."
      }
    }
  ],
  "relatedRaid": [],
  "spatialCoverage": [],
  "subject": [],
  "title": [
    {
      "endDate": "2024-06-30",
      "startDate": "2024-03-01",
      "text": "Pipeline Accelerator - Voucher Scheme - 23-24 Round 2",
      "type": {
        "id": "https://vocabulary.raid.org/title.type.schema/5",
        "schemaUri": "https://vocabulary.raid.org/title.type.schema/376"
      }
    }
  ]
}

Page generated: